Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma
| author |
|
| created | [InstanceEdit:2077391] Rothfels, K, 2012-01-27 |
| dbId | 2077392 |
| displayName | Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma |
| journal | Clin Cancer Res |
| pages | 6146-53 |
| pubMedIdentifier | 18829493 |
| schemaClass | LiteratureReference |
| title | Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma |
| url | http://www.ncbi.nlm.nih.gov/pubmed/18829493 |
| volume | 14 |
| year | 2008 |
Referrals
© 2026 Reactome
